European journal of cancer (Oxford, England : 1990)HumansBiomarkersTumorBreast NeoplasmsNeoplasms
International expert consensus on the clinical integration of circulating tumor cells in solid tumors.
Eleonora Nicolò, Carolina Reduzzi, Jean-Yves Pierga, Paola Gazzaniga, Nikolas H Stoecklein, Valeria Denninghoff, Dominic G Rothwell, Johann S De Bono, Dario Marchetti, Evi Lianidou, Sabine Riethdorf, Daniele Generali, Paul Hofman, Lorenzo Gerratana, Peter Kuhn
Published: 202510.1016/j.ejca.2025.116050
Abstract
BACKGROUND: Circulating tumor cells (CTCs) are a versatile biomarker in solid tumors. Extensive research supports their clinical relevance and led to regulatory approval in breast, prostate, and colorectal cancers. However, clinical adoption remains…
Preview only. Read the full abstract at the source